Remove Immunization Remove Insurance Remove White Paper
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

Monoclonal antibody drugs act via passive immunisation or a direct transfer of antibodies to a non-immune person for temporary protection, whereas vaccines offer active immunisation so patients can produce their own antiviral antibodies. The variety of options for RSV prevention can only be taken as a positive, she says.